Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 477

1.

Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses.

Mitra-Kaushik S, Cruz J, Stern LJ, Ennis FA, Terajima M.

J Immunol. 2007 Jul 15;179(2):1303-12.

2.

Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.

Terajima M, Cruz J, Leporati AM, Demkowicz WE Jr, Kennedy JS, Ennis FA.

Hum Immunol. 2006 Jul;67(7):512-20. Epub 2006 May 4.

PMID:
16829305
3.
4.

Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection.

Calvo-Calle JM, Strug I, Nastke MD, Baker SP, Stern LJ.

PLoS Pathog. 2007 Oct 12;3(10):1511-29.

5.

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.

Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J.

J Natl Cancer Inst. 1995 Jul 5;87(13):982-90.

PMID:
7629885
6.

Differences between T cell epitopes recognized after immunization and after infection.

Vogel TU, Horton H, Fuller DH, Carter DK, Vielhuber K, O'Connor DH, Shipley T, Fuller J, Sutter G, Erfle V, Wilson N, Picker LJ, Watkins DI.

J Immunol. 2002 Oct 15;169(8):4511-21.

7.

Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.

Correale P, Walmsley K, Zaremba S, Zhu M, Schlom J, Tsang KY.

J Immunol. 1998 Sep 15;161(6):3186-94.

8.

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

Drexler I, Staib C, Kastenmuller W, Stevanović S, Schmidt B, Lemonnier FA, Rammensee HG, Busch DH, Bernhard H, Erfle V, Sutter G.

Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):217-22. Epub 2002 Dec 23.

9.

Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.

BenMohamed L, Krishnan R, Longmate J, Auge C, Low L, Primus J, Diamond DJ.

Hum Immunol. 2000 Aug;61(8):764-79.

PMID:
10980387
11.
12.
13.

Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles.

Mathew A, Terajima M, West K, Green S, Rothman AL, Ennis FA, Kennedy JS.

J Immunol. 2005 Feb 15;174(4):2212-9.

14.

Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes.

Fujiki F, Oka Y, Tsuboi A, Kawakami M, Kawakatsu M, Nakajima H, Elisseeva OA, Harada Y, Ito K, Li Z, Tatsumi N, Sakaguchi N, Fujioka T, Masuda T, Yasukawa M, Udaka K, Kawase I, Oji Y, Sugiyama H.

J Immunother. 2007 Apr;30(3):282-93.

PMID:
17414319
15.
16.

Human CD4 T cell epitopes selective for Vaccinia versus Variola virus.

Probst A, Besse A, Favry E, Imbert G, Tanchou V, Castelli FA, Maillere B.

Mol Immunol. 2013 Apr;53(4):453-9. doi: 10.1016/j.molimm.2012.10.011. Epub 2012 Nov 10.

PMID:
23147561
17.

Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation.

Hural JA, Friedman RS, McNabb A, Steen SS, Henderson RA, Kalos M.

J Immunol. 2002 Jul 1;169(1):557-65.

18.

Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.

May RJ, Dao T, Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, Zhang RH, Maslak P, Scheinberg DA.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4547-55. Erratum in: Clin Cancer Res. 2007 Sep 1;13(17):5226.

19.

CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis.

Klyushnenkova EN, Ponniah S, Rodriguez A, Kodak J, Mann DL, Langerman A, Nishimura MI, Alexander RB.

J Immunother. 2004 Mar-Apr;27(2):136-46.

PMID:
14770085
20.

Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes.

Meiring HD, Kuipers B, van Gaans-van den Brink JA, Poelen MC, Timmermans H, Baart G, Brugghe H, van Schie J, Boog CJ, de Jong AP, van Els CA.

J Immunol. 2005 May 1;174(9):5636-43.

Supplemental Content

Support Center